nemu

HOME > NEWS

NEWS

Treatment of Cancer Use Patent for EP4 antagonist Approved in Canada

2016/02/09

AskAt received a notice of allowance dated February 9, 2016 from Canadian Intellectual Property Office in connection with the Application No. 2,754,702, a use patent of EP4 receptor antagonist for the treatment of Cancer.

 

PAGE TOP

Menu